Monday November 30, 2020 20:40

Heathcare Press Release : 03 Nov 2020

RevImmune advances new immunotherapy in COVID-19 Heathcare—03 Nov 20

RevImmune, a privately held biotech company based in Paris, France and Bethesda, MD, developing CYT107 (recombinant human Interleukin-7) for infectious diseases, sepsis and cancer, announced today that its "ILIAD-7" international randomized controlled